You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 359 Developing human placental CD34-derived natural killer cells with high affinity and cleavage resistant CD16 and secreted IL-15 (CYNK-201) for cancer immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
359 Developing human placental CD34-derived natural killer cells with high affinity and cleavage resistant CD16 and secreted IL-15 (CYNK-201) for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023292017
Dec 20238307
Jan 20244602
Feb 20242402
Mar 20243800
Apr 20246205
May 20243002
Jun 20242806
Jul 20242801
Aug 20242700
Sep 20242401
Oct 20242006
Nov 20242803
Dec 20241404
Jan 20252006
Feb 2025002
Mar 2025009
Apr 2025003
May 2025005
Jun 2025002
Total764083